Welcome to our dedicated page for Zepp Health SEC filings (Ticker: ZEPP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Zepp Health's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Zepp Health's regulatory disclosures and financial reporting.
Allspring Global Investments Holdings, LLC has filed Amendment No. 7 to Schedule 13G declaring its current ownership in Zepp Health Corp (symbol ZEPP) as of 30 June 2025.
- Shares owned: 9,757,152 American Depositary Receipts (ADRs).
- Ownership percentage: 8.7 % of the outstanding ADR class, exceeding the 5 % reporting threshold.
- Voting/dispositive power: Sole voting power and sole dispositive power over the entire position; no shared power reported.
- Holder classification: Designated as a Holding Company/Control person (Item 3 — HC).
- Stake origin: Securities are held for clients of subsidiaries Allspring Global Investments, LLC and Allspring Funds Management, LLC; no single client holds more than 5 % of the class.
- Intent statement: Filing certifies the position was acquired in the ordinary course of business and not to influence control of Zepp Health.
- Signatories & dates: Event date 06-30-2025; filing signed by Senior Compliance Manager Jennifer Grunberg on 07-14-2025.
This disclosure signals a sizeable passive institutional position in Zepp Health, potentially viewed by the market as a vote of confidence in the company’s prospects without implying activist intentions.